<p>Cells were diluted in RPMI 1640 medium containing FLC, AML, NIF, BEN, FNZ and combination of FLC with the four CCBs. The concentration of FLC was 1 μg ml<sup>-1</sup> when combined with AML (8 μg ml<sup>-1</sup>) and FNZ (16 μg ml<sup>-1</sup>), and the concentration of FLC was 2 μg ml<sup>-1</sup> when combined with NIF (8 μg ml<sup>-1</sup>) and BEN (16 μg ml<sup>-1</sup>). Values represent the means ±standard deviation of three replicates. * P < 0.01 and at least 2.0-fold compared to the fluconazole group.</p
<p>(a-f). Representative time kill curves of (a) <i>C</i>. <i>albicans</i> ATCC 90028 (b) FLC-suscep...
The antifungal agent fluconazole (FLC) is widely used in clinical practice. Monitoring FLC levels is...
Antimicrobial drug resistance can limit the ability to effectively treat patients. Numerous factors ...
A clear understanding of the pharmacodynamic properties of antifungal agents is important for the ad...
<p>(A). Relative expression of <i>CDR1</i>, <i>CDR1</i> and <i>MDR1</i> following treatment with flu...
Fluconazole is a novel triazole antifungal intended for oral treatment of superficial and systemic m...
<p>Time Kill of <i>C</i>. <i>albicans</i> (MYA 2876) inoculum (10³ CFU/ml) tested against lichochalc...
The aim of this study was to evaluate the in vitro activity of fluconazole against two yeast strains...
D0870 is a recently developed triazole with characteristics of a broad spectrum of activity and slow...
<p>FLC-resistant <i>C. albicans</i> 103 were treated with FLC (8 µg/ml), Gla (4 µg/ml) and FLC+Gla (...
10.1016/j.ijantimicag.2013.10.024The in vitro activities of fluconazole (FLC), amphotericin B (AmB) ...
The clinical correlation of fluconazole antifungal susceptibility testing (AST) for Candida isolates...
This study was designed to examine the effects of antifungal carryover, agitation, and starting inoc...
Candida inconspicua is an emerging pathogen in immunocompromised patients possessing inherently dec...
Several types of drugs currently used in clinical practice were screened in vitro for their potentia...
<p>(a-f). Representative time kill curves of (a) <i>C</i>. <i>albicans</i> ATCC 90028 (b) FLC-suscep...
The antifungal agent fluconazole (FLC) is widely used in clinical practice. Monitoring FLC levels is...
Antimicrobial drug resistance can limit the ability to effectively treat patients. Numerous factors ...
A clear understanding of the pharmacodynamic properties of antifungal agents is important for the ad...
<p>(A). Relative expression of <i>CDR1</i>, <i>CDR1</i> and <i>MDR1</i> following treatment with flu...
Fluconazole is a novel triazole antifungal intended for oral treatment of superficial and systemic m...
<p>Time Kill of <i>C</i>. <i>albicans</i> (MYA 2876) inoculum (10³ CFU/ml) tested against lichochalc...
The aim of this study was to evaluate the in vitro activity of fluconazole against two yeast strains...
D0870 is a recently developed triazole with characteristics of a broad spectrum of activity and slow...
<p>FLC-resistant <i>C. albicans</i> 103 were treated with FLC (8 µg/ml), Gla (4 µg/ml) and FLC+Gla (...
10.1016/j.ijantimicag.2013.10.024The in vitro activities of fluconazole (FLC), amphotericin B (AmB) ...
The clinical correlation of fluconazole antifungal susceptibility testing (AST) for Candida isolates...
This study was designed to examine the effects of antifungal carryover, agitation, and starting inoc...
Candida inconspicua is an emerging pathogen in immunocompromised patients possessing inherently dec...
Several types of drugs currently used in clinical practice were screened in vitro for their potentia...
<p>(a-f). Representative time kill curves of (a) <i>C</i>. <i>albicans</i> ATCC 90028 (b) FLC-suscep...
The antifungal agent fluconazole (FLC) is widely used in clinical practice. Monitoring FLC levels is...
Antimicrobial drug resistance can limit the ability to effectively treat patients. Numerous factors ...